Drug Treatment of Sleep Disorders

Lieferzeit: Lieferbar innerhalb 14 Tagen

106,99 €

inkl. 7 % MwSt. zzgl. Versandkosten

Milestones in Drug Therapy

ISBN: 3319379208
ISBN 13: 9783319379203
Herausgeber: Antonio Guglietta
Verlag: Springer Verlag GmbH
Umfang: viii, 297 S., 9 s/w Illustr., 14 farbige Illustr., 297 p. 23 illus., 14 illus. in color.
Erscheinungsdatum: 23.08.2016
Auflage: 1/2015
Produktform: Kartoniert
Einband: KT

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

Artikelnummer: 9752674 Kategorie:

Das könnte Ihnen auch gefallen …